Gurit Holding AG logo

Gurit Holding AG (GURN)

Market Closed
10 Aug, 15:20
SIX SIX
27. 70
CHF
-0.3
-1.0714%
CHF
170.97M Market Cap
80.8 P/E Ratio
2% Div Yield
6,680 Volume
45.62 Eps
28 CHF
Previous Close
Add Transaction
Day Range
27.7 28.3
Year Range
10.02 45.9
Want to track GURN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

GURN closed today lower at 27.7 CHF, a decrease of -1.0714% from yesterday's close, completing a monthly decrease of -32.439% or -13.3 CHF. Over the past 12 months, GURN stock gained 139.2055%.
GURN is not paying dividends to its shareholders.
The last earnings report, released on Mar 02, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -4.8633%, based on the last three reports.
Gurit Holding AG has completed 2 stock splits, with the recent split occurring on May 02, 2022.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on LSE (CHF).

GURN Chart

Gurit Holding AG (GURN) FAQ

What is the stock price today?

The current price is 27.70 CHF.

On which exchange is it traded?

Gurit Holding AG is listed on SIX.

What is its stock symbol?

The ticker symbol is GURN.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2%.

What is its market cap?

As of today, the market cap is 170.97M.

Has Gurit Holding AG ever had a stock split?

Gurit Holding AG had 2 splits and the recent split was on May 02, 2022.

Gurit Holding AG Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Javier Perez Freije CEO
SIX Exchange
CH1173567111 ISIN
Switzerland Country
2,291 Employees
22 Apr 2024 Last Dividend
3 May 2022 Last Split
- IPO Date

Overview

Mankind Pharma Limited is a prestigious entity in the pharmaceutical sector, with a focus on developing, manufacturing, and marketing an extensive range of pharmaceutical formulations and consumer healthcare products. With its roots firmly established in 1986 in New Delhi, India, the company has expanded its reach both nationally and internationally. Mankind Pharma's commitment to health extends beyond borders, covering a wide array of therapeutic areas that include acute and chronic conditions. It prides itself on being a leading provider of a variety of healthcare solutions, catering to diverse medical needs and ensuring wellness is accessible to all.

Products and Services

  • Pharmaceuticals: Mankind Pharma is renowned for its extensive portfolio of pharmaceutical products catering to various therapeutic domains such as anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. The company's dedication to quality and innovation ensures that each product meets the highest standards of safety and efficacy, addressing the complex needs of patients suffering from acute and chronic conditions.
  • Consumer Healthcare Products: Beyond conventional pharmaceuticals, Mankind Pharma offers a broad spectrum of consumer healthcare products. This range includes condoms under the brand Manforce, designed for safer sexual health; Prega News for pregnancy detection; emergency contraceptives like Unwanted-72 to provide options for women; Gas-O-Fas for relief from digestive issues; Health OK, a supplement for overall health; and AcneStar for skincare. Each product is developed with the consumer's health and well-being in mind, offering quality solutions for everyday health care needs.
  • Other Ventures: Mankind Pharma's business interests also extend into trading and exporting of pharmaceutical and healthcare products, underscoring its global vision. The company is involved in the manufacture of packing materials and ayurvedic products, highlighting its commitment to embracing traditional and alternative healthcare solutions. Furthermore, Mankind Pharma ventures into real estate, leasing, and hospitality, diversifying its portfolio while maintaining its core focus on health and wellness. The provision of IT services signifies the company's adaptation to digital advances, ensuring efficiency and modernization in its operations.

Contact Information

Address: Ebnaterstrasse 79
Phone: +44 20 7355 9810